Clinical Trial Update: Safety of Heparin in Patients With Septic Shock [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety of heparin in patients with septic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Sepsis | Phase 2 | Status: WITHDRAWN